GENERAL CONSIDERATIONS


Biologic Behaviour

•rare with an overall incidence of 0.17%

•however, salivary gland neoplasia comprises 30% of all salivary gland pathology

•majority of salivary gland tumors are malignant and epithelial (84%) with ADC most common

•other salivary gland tumors include mucoepidermoid carcinoma, complex carcinoma, cystadenocarcinoma, acinic cell carcinoma, undifferentiated carcinoma, SCC, OSA, FSA, giant cell tumor, MCT, and LSA

•major (i.e., parotid, mandibular, sublingual, and zygomatic) and minor accessory salivary glands can involved









•metastasis to the regional lymph node in 39% and distant sites in 16% cats

•metastasis to the regional lymph node in 17% and distant sites in 8% dogs

•benign salivary gland tumors are rare (compared to humans) although benign lipomatous infiltration, calcinosis circumscripta, and adenoma have been reported



CLINICAL FEATURES


Signalment

•age: older (> 10-12 years)

•breed predisposition: Siamese cats and Spaniel breeds

•sex predisposition: males in cats with a male-to-female ratio of 2:1, but no sex predilection in dogs


Clinical Signs

•clinical signs are non-specific and include halitosis, dysphagia, and exophthalmos

•unilateral firm, painless swelling of the:

•upper neck with mandibular and sublingual salivary gland tumors

•ear base with parotid salivary gland tumors

•upper lip or maxilla with zygomatic salivary gland tumors

•mucous membrane of lip or sublingual area with accessory salivary gland tumors

•DDx: mucocele, abscess, salivary gland infarction, sialadenitis, LSA, or reactive lymphadenopathy



DIAGNOSIS


General Considerations

•FNA to differentiate non-neoplastic from neoplastic masses

•regional radiographs to identify periosteal reaction or displacement of adjacent structures

•incisional biopsy for definitive diagnosis


Clinical Staging


























TREATMENT


Surgical Treatment

•surgery is recommended if possible but many lesions are extracapsular, invasive, and involve vital structures

•parotid gland resection is difficult due to poorly defined margins and facial nerve involvement

•complete extirpation of the ipsilateral neck can be performed with good functional outcome despite poor ability to blink and predisposition to KCS (treatment: tarsorrhaphy and eye drops)

•surgery and radiation therapy has been used to treat 3 cases with microscopic disease resulting in good local control and prolonged survival

•role of chemotherapy unknown


Prognosis

•MST 516 days in cats

•MST 550 days in dogs

•surgery and radiation therapy can provide permanent local control and long-term survival

•incomplete resection will result in local recurrence

•histologic grade is not prognostic for salivary gland ADC

•poor prognostic factors in cats: low mitotic index (≤ 10 v > 10)

•poor prognostic factors in dogs: stage III-IV disease v stage I-II disease

SURGICAL ONCOLOGY

SOCIETY

RESEARCH

EDUCATION

LINKS

EMPLOYMENT

 IMAGE LIBRARYImages.html
● HistoryHistory.html
● What is a Surgical OncologistSurgical_Oncology_1.html
● Find a Surgical OncologistSurgical_Oncology_2.html
● Aims and ObjectivesAims.html
● MembershipMembership.html
● CommitteesCommittees.html
● NewsletterNewsletter.html
● Constitution and BylawsConstitution.html
● Research TrialsResearch_Trials.html
● Publications by MembersPublications.html
● Research OpportunitiesResearch_Opportunities.html
● Cancer InformationCancer_Information_1.html
● Conferences and MeetingsConferences.html
● Radiation FacilitiesRadiation_Facilities.html
● CE OpportunitiesCE_Opportunities.html
● Cancer InformationCancer_Information_2.html
● Current OpportunitiesEmployment_Opportunities.html
● Fellowship Training GuidelinesFellowship_Guidelines.html

SALIVARY GLAND TUMORS

● Surgical Oncology JournalsJournals.html
● Surgical Oncology SocietiesSocieties.html
● Veterinary Surgery CollegesColleges.html

T0

No evidence of neoplasia

T1

Tumor < 2 cm in diameter

Primary Tumor

T2

Tumor 2-4 cm in diameter

T3

Tumor > 4 cm in diameter

N0

No evidence of lymph node involvement

N1

Regional lymph node involvement

Node

M0

No evidence of metastasis

M1

Evidence of distant metastasis with site specified

Metastasis

Clinical Stage

I

II

III

T

T1

T2-3

T1-3

N

N0

N0

N1

M

M0

M0

M0

IV

T1-3

N0-1

M1

Salivary Gland

Cat

Dog

Mandibular

59%

30%

Parotid

19%

50%

Sublingual and Minor Salivary Glands

6%

12%

Zygomatic

3%

4%

Undetermined Salivary Glands

13%

4%